Canada Health News API

{
    "totalArticles": 269308,
    "articles": [
        {
            "id": "cefa482ee02d5d52ed7a432c8e4f54f5",
            "title": "Pour bien décider, commençons par bien respirer",
            "description": "En agissant sur le rythme cardiaque et les circuits cérébraux de la récompense, certaines techniques de respiration peuvent influencer la prise de décision et rendre nos choix plus audacieux, selon des chercheurs.",
            "content": "Prendre un risque, saisir une opportunité ou au contraire jouer la prudence : ces choix pourraient dépendre davantage de votre respiration que vous ne l'imaginez. Une étude menée par des chercheurs allemands, publiée dans Neuron, révèle qu'un simple ... [2942 chars]",
            "url": "https://www.pourquoidocteur.fr/Articles/Question-d-actu/55105-Pour-decider-commencons-bien-respirer",
            "image": "https://www.pourquoidocteur.fr/media/article/istock-2227383479-1781604089.jpg",
            "publishedAt": "2026-06-16T17:25:00Z",
            "lang": "fr",
            "source": {
                "id": "fad2b3a2a712b01baad87009bb046440",
                "name": "Pourquoi Docteur",
                "url": "https://www.pourquoidocteur.fr"
            }
        },
        {
            "id": "930c1b9a670a7143ab4f35445ba60052",
            "title": "Exdensur (depemokimab injection) approved in Canada for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps",
            "description": "Exdensur is the first and only long-acting biologic with twice-yearly dosing approved in Canada for severe asthma characterized by an eosinophilic phenotype...",
            "content": "Exdensur is the first and only long-acting biologic with twice-yearly dosing approved in Canada for severe asthma characterized by an eosinophilic phenotype and chronic rhinosinusitis with nasal polyps (CRSwNP).\nIn Canada, approximately half of peopl... [8795 chars]",
            "url": "https://www.newswire.ca/news-releases/exdensur-depemokimab-injection-approved-in-canada-for-the-treatment-of-severe-asthma-and-chronic-rhinosinusitis-with-nasal-polyps-897336384.html",
            "image": "https://mma.prnewswire.com/media/2993399/GlaxoSmithKline_Inc__Exdensur__depemokimab_injection__approved_i.jpg?p=facebook",
            "publishedAt": "2026-06-16T16:13:00Z",
            "lang": "en",
            "source": {
                "id": "cf555e7a9ba184ade8de566542781f7e",
                "name": "Newswire Canada",
                "url": "https://www.newswire.ca"
            }
        },
        {
            "id": "e7f96d0e45d538f0fda49f2cf6101711",
            "title": "Brain Canada Announces Major Investment in Brain Research in Ontario",
            "description": "/CNW/ - Ontario is reinforcing its leadership as a centre of excellence in brain research, with four new Brain Canada–supported platforms that will accelerate...",
            "content": "Platforms in Toronto, London, and Hamilton aim to speed diagnosis, improve mental health care, and unlock the brain\nTORONTO, June 16, 2026 /CNW/ - Ontario is reinforcing its leadership as a centre of excellence in brain research, with four new Brain ... [4750 chars]",
            "url": "https://www.newswire.ca/news-releases/brain-canada-announces-major-investment-in-brain-research-in-ontario-801584616.html",
            "image": "https://mmx.prnewswire.com/media/MS1103391/Brain_Canada-Brain_Canada_Announces_Major_Investment_in_Brain_Re.jpg?id=OA2719016&p=facebook",
            "publishedAt": "2026-06-16T16:05:00Z",
            "lang": "en",
            "source": {
                "id": "cf555e7a9ba184ade8de566542781f7e",
                "name": "Newswire Canada",
                "url": "https://www.newswire.ca"
            }
        }
    ]
}